# ED90 of Bupivacaine After Lidocaine Test Dose with DPE and EPL

> **NCT06146842** · PHASE4 · RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Labor Pain

## Interventions

- **DRUG:** Bupivacaine Hydrochloride

## Key facts

- **NCT ID:** NCT06146842
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-12-01
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06146842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06146842, "ED90 of Bupivacaine After Lidocaine Test Dose with DPE and EPL". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06146842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*